The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium Channel
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
The inward rectification mechanism of the HERG cardiac potassium channel
Smith, P. L., Baukrowitz, T., & Yellen, G. (1996) · Nature · doi:10.1038/379833a0 · Cited by 754
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels
Zhang, S., Zhou, Z., Gong, Q., Makielski, J. C., & January, C. T. (1999) · Circulation Research · doi:10.1161/01.res.84.9.989 · Cited by 366
Rampe, D., Roy, M.-L., Dennis, A., & Brown, A. M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01249-0 · Cited by 293
Kang, J., Wang, L., Chen, X.-L., Triggle, D. J., & Rampe, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12364-4 · Cited by 282
Progress in predicting human ADME parameters in silico
Ekins, S., Waller, C. L., Swaan, P. W., Cruciani, G., Wrighton, S. A., & Wikel, J. H. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00109-x · Cited by 274
Self-citationQT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050714 · Cited by 240
Suessbrich, H., Schönherr, R., Heinemann, S. H., Attali, B., Lang, F. J. W., & Busch, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700989 · Cited by 229
Blockage of the HERG human cardiac K+channel by the gastrointestinal prokinetic agent cisapride
Mohammad, S., Zhou, Z., Gong, Q., & January, C. T. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.5.h2534 · Cited by 224
Teschemacher, A. G., Seward, E. P., Hancox, J. C., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702800 · Cited by 135
Crumb, W., & Cavero, I. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00172-8 · Cited by 118
Self-citationBlockade of HERG and Kv1.5 by Ketoconazole
Dumaine, R., Roy, M. L., & Brown, A. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37646-3 · Cited by 111
Geelen, P., Drolet, B., Rail, J., Bérubé, J., Daleau, P., Rousseau, G., Cardinal, R., O’Hara, G. E., & Turgeon, J. (2000) · Circulation · doi:10.1161/01.cir.102.3.275 · Cited by 95
Crumb, W. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35285-1 · Cited by 90
Self-citationIn silico ADME/Tox: the state of the art
Ekins, S., & Rose, J. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00127-9 · Cited by 85
Self-citationHuman Ether-a-gogo Related Gene (HERG) K Channels as Pharmacological Targets
Taglialatela, M., Castaldo, P., Pannaccione, A., Giorgio, G., & Annunziato, L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00002-1 · Cited by 67
Inhibition of HERG potassium channels by the antimalarial agent halofantrine
Tie, H., Walker, B. D., Singleton, C. B., Valenzuela, S. M., Bursill, J. A., Wyse, K. R., Breit, S. N., & Campbell, T. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703470 · Cited by 62
Rees, S., & Curtis, M. J. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02063-2 · Cited by 42
Inactivation gating determines nicotine blockade of human HERG channels
Wang, H., Shi, H., Liao, S.-J., & Wang, Z. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h1081 · Cited by 20
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
hERG K+Channels: Structure, Function, and Clinical Significance
Vandenberg, J. I., Perry, M. D., Perrin, M. J., Mann, S. A., Ke, Y., & Hill, A. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00036.2011 · Cited by 696
Metadata
- Authors
- Ekins, S., Crumb, W. J., Sarazan, R. D., Wikel, J. H., & Wrighton, S. A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 301
- Issue
- 2
- Pages
- 427-434
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2130566541
- Cited by
- 260
- References
- 22
- FWCI
- 18.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.